Tourmaline Bio Inc (TRML) Volatility Spurs A Quest For Clarity
Currently, there are 20.34M common shares owned by the public and among those 15.32M shares have been available to trade. The company’s stock has a 5-day price change of -0.45% and -61.44% over the past three months. TRML shares are trading -40.60% year to date (YTD), with the 12-month market performance down to -36.27% lower. […]
